Imperial College London
Alternate

Dr Francine Heatley

Faculty of Medicine, Department of Surgery & Cancer

Clinical Trials Manager
 
 
 
//

Contact

 

+44 (0)20 3311 7371f.heatley Website

 
 
//

Location

 

3E4East WingCharing Cross Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Salim:2021:10.1177/0268355520966893,
author = {Salim, S and Heatley, F and Bolton, L and Khatri, A and Onida, S and Davies, AH},
doi = {10.1177/0268355520966893},
journal = {Phlebology},
pages = {203--208},
title = {The management of venous leg ulceration post the EVRA (early venous reflux ablation) ulcer trial: Management of venous ulceration post EVRA},
url = {http://dx.doi.org/10.1177/0268355520966893},
volume = {36},
year = {2021}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - ObjectivesThis survey study evaluates current management strategies for venous ulceration and the impacts of the EVRA trial results.MethodsAn online survey was disseminated to approximately 15000 clinicians, through 12 vascular societies in 2018. Survey themes included: referral times, treatment times and strategies, knowledge of the EVRA trial and service barriers to managing venous ulceration. Data analysis was performed using Microsoft Excel and SPSS.Results664 responses were received from 78 countries. Respondents were predominantly European (55%) and North American (23%) vascular surgeons (74%). Responses varied between different countries. The median vascular clinic referral time was 6 weeks and time to be seen in clinic was 2 weeks. This was significantly higher in the UK (p ≤ 0.02). 77% of respondents performed surgical/endovenous interventions prior to ulcer healing, the median time to intervention was 4 weeks. 31% of participants changed their practice following EVRA. Frequently encountered barriers to implementing change were a lack of operating space/time (18%).ConclusionVenous ulcers are not managed as quickly as they should be. An evaluation of local resource requirements should be performed to improve service provision for venous ulceration. When interpreting the results of this survey consideration should be given to the response rate.
AU  - Salim,S
AU  - Heatley,F
AU  - Bolton,L
AU  - Khatri,A
AU  - Onida,S
AU  - Davies,AH
DO  - 10.1177/0268355520966893
EP  - 208
PY  - 2021///
SN  - 0268-3555
SP  - 203
TI  - The management of venous leg ulceration post the EVRA (early venous reflux ablation) ulcer trial: Management of venous ulceration post EVRA
T2  - Phlebology
UR  - http://dx.doi.org/10.1177/0268355520966893
UR  - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000625255700001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR  - https://journals.sagepub.com/doi/10.1177/0268355520966893
UR  - http://hdl.handle.net/10044/1/89464
VL  - 36
ER  -
Download